A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma

This study tests whether oral semaglutide — a medication commonly used for diabetes and weight loss — can also help protect vision in people with a type of glaucoma called open-angle glaucoma. Glaucoma slowly damages the optic nerve and can lead to blindness if untreated. **You may be eligible if...** - You are 45 or older with a diagnosis of primary open-angle glaucoma - You are already on eye pressure-lowering treatment - Your vision in the study eye meets minimum standards - You can speak and read Danish **You may NOT be eligible if...** - You have diabetes or kidney problems - You have had other significant eye conditions or eye surgery in the past 3 months - You are pregnant, breastfeeding, or currently a smoker - You are not using adequate contraception (if applicable) Talk to your doctor to see if this trial is right for you.